NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,446,000 | +0.6% | 1,534,000 | 0.0% | 0.04% | +5.1% |
Q2 2022 | $1,438,000 | -12.5% | 1,534,000 | 0.0% | 0.04% | +2.6% |
Q1 2022 | $1,643,000 | -6.9% | 1,534,000 | -2.6% | 0.04% | +5.6% |
Q4 2021 | $1,764,000 | -14.0% | 1,575,000 | +3.7% | 0.04% | -20.0% |
Q3 2021 | $2,050,000 | +73.0% | 1,519,000 | +122.7% | 0.04% | +66.7% |
Q2 2021 | $1,185,000 | – | 682,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 9,000,000 | $135,324,000 | 1.71% |
DeepCurrents Investment Group LLC | 21,930,000 | $33,750,000 | 1.16% |
WOLVERINE ASSET MANAGEMENT LLC | 44,534,000 | $69,564,000 | 0.59% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,208,000 | 0.38% |
Context Capital Management, LLC | 2,000 | $3,084,000 | 0.30% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,276,000 | 0.27% |
Polar Asset Management Partners Inc. | 17,500,000 | $26,683,000 | 0.26% |
CSS LLC/IL | 2,500,000 | $3,780,000 | 0.16% |
Verition Fund Management LLC | 7,486,000 | $11,543,000 | 0.13% |
PFM Health Sciences, LP | 2,000,000 | $3,032,000 | 0.09% |